Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABBV
ABBV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABBV News
TEPKINLY Receives EU Approval for Relapsed Lymphoma Treatment
1d ago
PRnewswire
AbbVie Receives EU Approval for TEPKINLY in Follicular Lymphoma Treatment
1d ago
PRnewswire
Novo Nordisk Faces Challenges but Optimistic Outlook Ahead
14h ago
Fool
U.S. Healthcare Spending Reaches $5.7 Trillion Amid Growth Trends
16h ago
Fool
Eli Lilly and Intuitive Surgical's Growth Potential
16h ago
NASDAQ.COM
European Commission Approves Tepkinly Label Expansion for Blood Cancer Therapy
18h ago
seekingalpha
Investors Concerned About Returns on AI Spending Amid Market Volatility
18h ago
Newsfilter
Jefferies Recommends Low-Stress Quality Stocks Amid AI Volatility
19h ago
CNBC
Top High-Dividend Stocks in Healthcare Sector
20h ago
Fool
Conexeu Completes CXU Preclinical Phase, Targeting Medical Aesthetics Market
20h ago
Newsfilter
Conexeu Completes CXU Preclinical Program for Medical Aesthetics Market Entry
21h ago
PRnewswire
iShares Core High Dividend ETF Outperforms S&P 500
1d ago
Fool
iShares Core High Dividend ETF Surges Over 15% Year-to-Date
1d ago
NASDAQ.COM
Apple's Stock Decline Raises Investor Concerns
1d ago
NASDAQ.COM
Apple Loses $500 Billion Market Cap Amid AI Concerns
1d ago
Fool
AbbVie Secures Marketing Authorization for TEPKINLY
1d ago
NASDAQ.COM
Show More News
